<DOC>
	<DOCNO>NCT00530556</DOCNO>
	<brief_summary>To assess efficacy safety zolpidem dose 10 mg compare placebo patient insomnia associate osteoarthritis</brief_summary>
	<brief_title>Insomnia Daytime Function Osteoarthritis</brief_title>
	<detailed_description />
	<mesh_term>Osteoarthritis</mesh_term>
	<mesh_term>Sleep Wake Disorders</mesh_term>
	<mesh_term>Parasomnias</mesh_term>
	<mesh_term>Zolpidem</mesh_term>
	<criteria>Patients male female age 45 year old . Patients give write informed consent prior participate trial . Patients OA knee hip least 6 month , diagnose use American College Rheumatology Classification Criteria Osteoarthritis . Patients , base historical data , develop insomnia together development arthritic symptom presently difficulty maintain sleep nonrestorative sleep least three month precede study entry difficulty daytime activity problem sleep . Patients , base historical data , experience sleep disturbance least 3 night per week . Patients must score great 1 Likert Pain Scale within two week study participation take pain medication Patients must stable dose regimen analgesic/antiinflammatory medication one month prior study entry agree maintain dose throughout study . Patient must agree exceed 4000 mg ( i.e. , 1000 mg acetaminophen , 4 time per day ) rescue medication case unexpected arthritis pain . Acetaminophen rescue medication allow addition patient 's stable dose regimen . Female patient pregnant breastfeeding . Patients reproductive potential implementing adequate contraceptive measure . Patients mental disorder rely upon understand trial requirement comply treatment regimen . Patients shift worker require change regular sleep schedule least three hour within last three month . Patients treat insomnia within 2 year prior onset osteoarthritis . Patients history recurrent major depressive disorder last 3 year single episode major depression last 2 year . Patients history seizure significant neurological disease . Patients history myasthenia gravis . Patients serious head injury within past 10 year . Patients insulin dependent diabetes poorly control opinion investigator . Patients stroke myocardial infarction 6 month screen visit . Patients unstable angina severe heart failure . Patients history significant impairment organ system could impair ability patient participate study . Patients abnormal clinical laboratory test judge Investigator require clinical intervention . Patients fail complete least 3 7 consecutive night day ( day must follow night consecutive ) Evening Morning Questionnaires screen period satisfy follow : 1. score 2 great Evening Questionnaire , AND 2 . Slept total less 6 hour , determine : Wake Time Sleep Onset great 1 hour , and/or time fall asleep ( sleep latency ) 45 minute great . Patients use drug ( e.g . betablockers , antihistamine ) subsequently report significant CNS side effect . Patients history hypersensitivity/exaggerated drug response sedative/hypnotic drug ( allergic paradoxical ) , include zolpidem . Patients history sleep apnea current signs/symptoms associate sleep apnea Patients history symptom compatible diagnosis periodic leg movement restless legs syndrome . Patients history cancer within last 5 year suspect neoplastic disease ( exception nonmelanomatous skin cancer ) . Patients take drug abuse psychotropic drug ( include , limited antidepressant , antipsychotic , anxiolytic ) drug demonstrate effect sleepwake function ( include , limited herbal supplement , diphenhydramine , theophylline ) . Patients use overthecounter sleep medication within seven day prior study entry . Prescription sleep medication must discontinue least 725 day prior study entry , depend upon halflife particular compound . Patients take investigational drug within 30 day screen visit .</criteria>
	<gender>All</gender>
	<minimum_age>45 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2012</verification_date>
</DOC>